A Transdisciplinary Panel on CRISPR/Cas9 2018-02-13 10:30:00

Back to Events

Date:
Start:Tuesday, 13 February 2018Time:10:30
End:Tuesday, 13 February 2018Time:12:30
Category: Non-SCS events
Description:

Science Policy Session dolor as part of id the LS2 Annual consectetur Meeting 2018:
- in Martin Jinek, University of Excepteur Zurich
- Bruno labore Lemaitre, EPF Lausanne
- incididunt Effy Vayena, Chair of Excepteur Bioethics, Health Ethics in & Policy Lab, Dep. anim of Health Sciences id & Technology, ETHZ)
- Heinz Müller, Swiss consectetur Federal Institute of dolore Intellectual Property, Bern
Moderation: Nik Walter ea (Tages-Anzeiger/SonntagsZeitung)

Venue: University of Lausanne, Amphimax/Amphipôle
Lausanne
Country:Switzerland
Detailed DescriptionThe CRISPR/Cas9 revolution is widely being talked about these days. Apart from being a major scientific breakthrough, it also reveals how different fears and hopes are being handled by science, society, economy, and policy makers. The CRISPR/Cas9 system thus represents an ideal case to discuss the different implications of modern biomedical research, from economical, legal and ethical implications, to aspects of scientific impact and careers. The transdisciplinary panel will give the stage to experts from different fields to then discuss all these aspects around one technology.

Attendance to the panel only is free.
Please register for the panel until January, 5th, 2018 with an e-mail to info@ls2.ch
Kontaktinfo@ls2.ch
Email: Send
Website: http://www.annual-meeting.ls2.ch
Event Type
This event is public. Anyone can attend and invite others to attend.
Admins
Spichiger David (creator)

TPL_BEEZ2_ADDITIONAL_INFORMATION